Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada

Clinical trial NCT07370766 · RECRUITING

Trial details

NCT number: NCT07370766
Sponsor: Chronicle Academy
Status: RECRUITING
Study type: OBSERVATIONAL

Psoriasis (PsO)Moderate to Severe Psoriasis

Start date: 2025-11-25
Primary completion: 2027-05-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.